NASDAQ:UTMD - Utah Medical Products Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $86.32 -0.17 (-0.20 %) (As of 01/18/2019 04:00 PM ET)Previous Close$86.49Today's Range$84.69 - $89.5552-Week Range$73.98 - $117.65Volume12,400 shsAverage Volume12,515 shsMarket Capitalization$316.14 millionP/E Ratio20.45Dividend Yield1.30%Beta0.72 ProfileDiscussionChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and UTMD supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah. Receive UTMD News and Ratings via Email Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:UTMD Previous Symbol CUSIP91748810 Webwww.utahmed.com Phone801-566-1200Debt Debt-to-Equity RatioN/A Current Ratio12.38 Quick Ratio11.35Price-To-Earnings Trailing P/E Ratio20.45 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$41.41 million Price / Sales7.78 Cash Flow$4.7507 per share Price / Cash Flow18.17 Book Value$21.00 per share Price / Book4.11Profitability EPS (Most Recent Fiscal Year)N/A Net Income$8.50 million Net Margins29.78% Return on Equity18.64% Return on Assets16.08%Miscellaneous Employees183 Outstanding Shares3,734,000Market Cap$316.14 million OptionableNot Optionable Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions What is Utah Medical Products' stock symbol? Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD." How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products? Utah Medical Products declared a quarterly dividend on Tuesday, October 30th. Shareholders of record on Friday, December 14th will be given a dividend of $0.275 per share on Thursday, January 3rd. This represents a $1.10 annualized dividend and a yield of 1.27%. The ex-dividend date is Thursday, December 13th. This is a boost from Utah Medical Products's previous quarterly dividend of $0.27. View Utah Medical Products' Dividend History. How were Utah Medical Products' earnings last quarter? Utah Medical Products, Inc. (NASDAQ:UTMD) released its earnings results on Tuesday, October, 23rd. The medical instruments supplier reported $0.95 EPS for the quarter. The medical instruments supplier had revenue of $10.39 million for the quarter. Utah Medical Products had a return on equity of 18.64% and a net margin of 29.78%. View Utah Medical Products' Earnings History. When is Utah Medical Products' next earnings date? Utah Medical Products is scheduled to release their next quarterly earnings announcement on Tuesday, January 29th 2019. View Earnings Estimates for Utah Medical Products. Has Utah Medical Products been receiving favorable news coverage? News coverage about UTMD stock has been trending positive on Friday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Utah Medical Products earned a coverage optimism score of 2.8 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. Who are some of Utah Medical Products' key competitors? Some companies that are related to Utah Medical Products include Nevro (NVRO), K2M Group (KTWO), AtriCure (ATRC), Tactile Systems Technology (TCMD), Luminex (LMNX), Cryolife (CRY), Orthofix Medical (OFIX), Cardiovascular Systems (CSII), Intersect ENT (XENT), AngioDynamics (ANGO), Cerus (CERS), OraSure Technologies (OSUR), SurModics (SRDX), SI-Bone (SIBN) and Anika Therapeutics (ANIK). Who are Utah Medical Products' key executives? Utah Medical Products' management team includes the folowing people: Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 71)Mr. Brian L. Koopman, Principal Financial Officer & Controller Who are Utah Medical Products' major shareholders? Utah Medical Products' stock is owned by many different of retail and institutional investors. Top institutional investors include Cardinal Capital Management (0.27%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Ernst G Hoyer and Kevin L Cornwell. View Institutional Ownership Trends for Utah Medical Products. Which major investors are buying Utah Medical Products stock? UTMD stock was bought by a variety of institutional investors in the last quarter, including Cardinal Capital Management. View Insider Buying and Selling for Utah Medical Products. How do I buy shares of Utah Medical Products? Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Utah Medical Products' stock price today? One share of UTMD stock can currently be purchased for approximately $86.32. How big of a company is Utah Medical Products? Utah Medical Products has a market capitalization of $316.14 million and generates $41.41 million in revenue each year. Utah Medical Products employs 183 workers across the globe. What is Utah Medical Products' official website? The official website for Utah Medical Products is http://www.utahmed.com. How can I contact Utah Medical Products? Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200. MarketBeat Community Rating for Utah Medical Products (NASDAQ UTMD)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 104 (Vote Outperform)Underperform Votes: 131 (Vote Underperform)Total Votes: 235MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe UTMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UTMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/18/2019 by MarketBeat.com StaffFeatured Article: What is an SEC Filing?